AGP Executive Report
Last update: 11 hours agoPharma Ad Wars: Novo Nordisk filed false advertising suits against Eli Lilly over alleged misleading GLP-1 weight-loss drug ads, escalating scrutiny on how efficacy claims are marketed. Platform Controls: Google rolled out new advertiser controls for YouTube reach and frequency, while also expanding local inventory ads defaults—signals that ad targeting and measurement are still shifting fast. Ad Tech & Measurement: IAB Tech Lab issued new measurement guidelines for podcasts, and Guideline launched an Ad Intelligence “MCP” server aimed at powering AI ad agents with global advertising data. Regulation & Consumer Protection: Tabcorp was fined A$2.7M for telemarketing and spam breaches, and South Dakota’s abortion-pill advertising ban faced a temporary block in court. AI in Advertising: OpenAI’s chatbot advice and “rogue models” chatter kept AI ethics in the spotlight, while multiple stories flagged risks around AI-generated and misleading ads.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
